Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD.

Karama S, Grizenko N, Sonuga-Barke E, Doyle A, Biederman J, Mbekou V, Polotskaia A, Ter-Stepanian M, De Guzman R, Bellingham J, Sengupta S, Joober R.

BMC Psychiatry. 2008 Jun 17;8:45. doi: 10.1186/1471-244X-8-45.

2.

Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder.

Agudelo JA, Gálvez JM, Fonseca DJ, Mateus HE, Talero-Gutiérrez C, Velez-Van-Meerbeke A.

Neurologia. 2015 Apr;30(3):137-43. doi: 10.1016/j.nrl.2013.12.005. Epub 2014 Jan 23. English, Spanish.

3.

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.

Joober R, Grizenko N, Sengupta S, Amor LB, Schmitz N, Schwartz G, Karama S, Lageix P, Fathalli F, Torkaman-Zehi A, Ter Stepanian M.

Neuropsychopharmacology. 2007 Jun;32(6):1370-6. Epub 2006 Oct 25.

4.

A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.

Šerý O, Paclt I, Drtílková I, Theiner P, Kopečková M, Zvolský P, Balcar VJ.

Behav Brain Funct. 2015 Jun 11;11:21. doi: 10.1186/s12993-015-0066-8.

5.

No association between VNTR polymorphisms of dopamine transporter gene and attention deficit hyperactivity disorder in Chinese children.

Cheuk DK, Li SY, Wong V.

Am J Med Genet B Neuropsychiatr Genet. 2006 Mar 5;141B(2):123-5.

PMID:
16402340
6.
7.

Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.

Bellgrove MA, Barry E, Johnson KA, Cox M, Dáibhis A, Daly M, Hawi Z, Lambert D, Fitzgerald M, McNicholas F, Robertson IH, Gill M, Kirley A.

Neuropsychopharmacology. 2008 Sep;33(10):2536-45. Epub 2007 Nov 28.

8.

A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD.

Rommelse NN, Altink ME, Arias-Vásquez A, Buschgens CJ, Fliers E, Faraone SV, Buitelaar JK, Sergeant JA, Franke B, Oosterlaan J.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1536-46. doi: 10.1002/ajmg.b.30848. Review.

PMID:
18729135
9.

Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents?

Ballon N, Leroy S, Roy C, Bourdel MC, Olie JP, Charles-Nicolas A, Krebs MO, Poirier MF.

Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1034-41.

PMID:
17671965
10.

Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.

Laucht M, Skowronek MH, Becker K, Schmidt MH, Esser G, Schulze TG, Rietschel M.

Arch Gen Psychiatry. 2007 May;64(5):585-90.

PMID:
17485610
11.

Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD.

Franke B, Hoogman M, Arias Vasquez A, Heister JG, Savelkoul PJ, Naber M, Scheffer H, Kiemeney LA, Kan CC, Kooij JJ, Buitelaar JK.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1576-9. doi: 10.1002/ajmg.b.30861.

PMID:
18802924
12.

Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue.

Brookes KJ, Neale BM, Sugden K, Khan N, Asherson P, D'Souza UM.

Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1070-8.

PMID:
17579365
13.

Crack cocaine users show differences in genotype frequencies of the 3' UTR variable number of tandem repeats of the dopamine transporter gene (DAT1/SLC6A3).

Stolf AR, Szobot CM, Halpern R, Akutagava-Martins GC, Müller D, Guimaraes LS, Kessler FH, Pechansky F, Roman T.

Neuropsychobiology. 2014;70(1):44-51. doi: 10.1159/000365992. Epub 2014 Sep 19.

PMID:
25247548
14.

Lack of association between a 3'UTR VNTR polymorphism of dopamine transporter gene (SLC6A3) and ADHD in a Brazilian sample of adult patients.

Aparecida da Silva M, Cordeiro Q, Louzã M, Vallada H.

J Atten Disord. 2011 May;15(4):305-9. doi: 10.1177/1087054710365989. Epub 2010 Mar 23.

PMID:
20332413
15.

Dopamine transporter genotype and methylphenidate dose response in children with ADHD.

Stein MA, Waldman ID, Sarampote CS, Seymour KE, Robb AS, Conlon C, Kim SJ, Cook EH.

Neuropsychopharmacology. 2005 Jul;30(7):1374-82.

16.

Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.

Pasini A, Sinibaldi L, Paloscia C, Douzgou S, Pitzianti MB, Romeo E, Curatolo P, Pizzuti A.

Eur J Paediatr Neurol. 2013 Jul;17(4):407-14. doi: 10.1016/j.ejpn.2013.02.002. Epub 2013 Mar 28.

PMID:
23541676
17.

Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD).

Feng Y, Wigg KG, Makkar R, Ickowicz A, Pathare T, Tannock R, Roberts W, Malone M, Kennedy JL, Schachar R, Barr CL.

Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5;139B(1):1-6.

PMID:
16082693
18.

Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): a family-based approach.

Lim MH, Kim HW, Paik KC, Cho SC, Yoon DY, Lee HJ.

Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):309-11.

PMID:
16526026
19.

Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.

Bellgrove MA, Johnson KA, Barry E, Mulligan A, Hawi Z, Gill M, Robertson I, Chambers CD.

Arch Gen Psychiatry. 2009 Oct;66(10):1135-42. doi: 10.1001/archgenpsychiatry.2009.120.

PMID:
19805704

Supplemental Content

Support Center